Enhancement of paclitaxel-induced apoptosis by inhibition of mitogen-activated protein kinase pathway in colon cancer cells.
about
Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasisSecurin enhances the anti-cancer effects of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075) in human colorectal cancer cellsIntegrated analysis of gene expression profiles associated with response of platinum/paclitaxel-based treatment in epithelial ovarian cancerCodelivery of doxorubicin and paclitaxel by cross-linked multilamellar liposome enables synergistic antitumor activity.Cancerous stem cells: deviant stem cells with cancer-causing misbehavior.RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells.Nuclear localization signal domain of HDAC3 is necessary and sufficient for the expression regulation of MDR1.miR-326-histone deacetylase-3 feedback loop regulates the invasion and tumorigenic and angiogenic response to anti-cancer drugs.MicroRNA-7 sensitizes non-small cell lung cancer cells to paclitaxel.Tubulin Beta3 Serves as a Target of HDAC3 and Mediates Resistance to Microtubule-Targeting Drugs.Cholesteryl butyrate solid lipid nanoparticles inhibit the adhesion and migration of colon cancer cells.Platelets increase survival of adenocarcinoma cells challenged with anticancer drugs: mechanisms and implications for chemoresistance.AKT-phosphorylated FOXO1 suppresses ERK activation and chemoresistance by disrupting IQGAP1-MAPK interaction.Induction of B7-H1 expression by human cytomegalovirus in extravillous cytotrophoblast cells and role of MAPK pathway.Synergistic inhibition of colon cancer cell growth with nanoemulsion-loaded paclitaxel and PI3K/mTOR dual inhibitor BEZ235 through apoptosis.Paclitaxel suppresses proliferation and induces apoptosis through regulation of ROS and the AKT/MAPK signaling pathway in canine mammary gland tumor cells.
P2860
Q26858839-44E11F21-EB75-4B91-89AC-3BB065A3FCD8Q28482641-912C3F1F-2B0F-49CA-985E-2E713DCD8270Q28484592-2201CBF5-773B-43E9-9B47-D6D8380EC1D8Q33598842-CBF12816-35EB-4F3B-96F3-0EFD5A195A05Q33999466-27C0242F-A601-4F03-A0F7-4216080EC99EQ34048144-77FBC5FB-0FC0-4B8B-A42C-B0E6A6984986Q34179956-B8AB5EAD-C16D-4598-BA59-FCF92C75B91BQ34283601-7710FD3A-5159-416F-B47E-91A9932DBDDBQ34293127-DFB8144C-7F6A-4FEF-8842-6C91B024DF34Q35988876-EFF8EC88-9007-4F13-B4D7-9F2856AD9026Q36159180-43D9AD10-A4C1-4881-A9AF-0450DF348A04Q36619756-F70F1994-904D-403C-9B8C-9D105AF20CD6Q38712894-04AF9F33-9225-4524-A12A-407B457C2220Q38956189-4C8B0EFE-01AE-4E9C-B221-1D48598A427BQ39735209-59211D23-6FE7-42E2-8409-016FBC7AEAA4Q52719198-D12069BA-5800-4670-A8DD-1CD36D083626
P2860
Enhancement of paclitaxel-induced apoptosis by inhibition of mitogen-activated protein kinase pathway in colon cancer cells.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Enhancement of paclitaxel-indu ...... pathway in colon cancer cells.
@ast
Enhancement of paclitaxel-indu ...... pathway in colon cancer cells.
@en
type
label
Enhancement of paclitaxel-indu ...... pathway in colon cancer cells.
@ast
Enhancement of paclitaxel-indu ...... pathway in colon cancer cells.
@en
prefLabel
Enhancement of paclitaxel-indu ...... pathway in colon cancer cells.
@ast
Enhancement of paclitaxel-indu ...... pathway in colon cancer cells.
@en
P2093
P1433
P1476
Enhancement of paclitaxel-indu ...... pathway in colon cancer cells.
@en
P2093
Junji Wada
Kenichio Koga
Kosuke Yanai
Masafumi Nakamura
Mitsuo Katano
Norihiro Sato
Ryuichi Mibu
Shuntaro Nagai
Takashi Akiyoshi
P304
P407
P577
2009-01-01T00:00:00Z